Spectral AI Inc（MDAI）股票分析MDAISpectral AI Inc

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. It is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Given the current price of $1.57 and the forward P/E ratio of 52.36, the stock is not an attractive buy at this moment. While the recent FDA clearance for the DeepView System is a positive catalyst, the RSI at 37.84 indicates that the stock is oversold, suggesting potential for recovery. However, the net income has been negative, with a loss of $4,176,000 in Q2 2026, which poses a significant risk.